Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis

被引:115
作者
Rottoli, P
Magi, B
Perari, MG
Liberatori, S
Nikiforakis, N
Bargagli, E
Cianti, R
Bini, L
Pallini, V
机构
[1] Univ Siena, Dept Clin Med & Immunol Sci, Resp Dis Sect, I-53100 Siena, Italy
[2] Univ Siena, Dept Biol Mol, I-53100 Siena, Italy
关键词
bronchoalveolar lavage; cytokines; interstitial lung diseases; proteome;
D O I
10.1002/pmic.200301007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to analyze the type of immune response (Th1, Th2) and protein composition of bronchoalveolar lavage (BAL) of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF). Flow cytometry analysis of intracellular cytokines revealed different patterns: in IPF and SSc Th2 profiles were predominant, whereas in sarcoidosis Th1 prevailed. The proteomic analysis of BAL fluid (BALF) showed that there were quantitative differences between the three diseases. These were more evident between sarcoidosis and IPF, confirming our previous observations, whereas SSc had an intermediate profile between the two, however with some peculiarities. Comparison of BALF protein maps, constructed with the same quantity of total proteins, enabled us to identify the main profiles of the three diseases: an increase in plasma protein prevalent in sarcoidosis and also present in SSc, though for fewer proteins with respect to IPF and a greater abundance of low molecular weight proteins, mainly locally produced, in IPF. These findings are in line with the different pathogenesis of these diseases: IPF is considered a prevalently fibrotic disorder limited to the lung, with intense local production of functionally different proteins, whereas sarcoidosis and SSc are systemic immunoinflammatory diseases.
引用
收藏
页码:1423 / 1430
页数:8
相关论文
共 54 条
[1]  
Ames PRJ, 1997, BRIT J RHEUMATOL, V36, P1045
[2]  
Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO
[3]  
2-L
[4]   Measurement of ceruloplasmin in the lungs of patients with acute respiratory distress syndrome: Is plasma or local production the major source? [J].
Baker, CS ;
Evans, TW ;
Haslam, PL .
RESPIRATION, 2000, 67 (05) :533-538
[5]   Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation [J].
Baugh, JA ;
Donnelly, SC .
JOURNAL OF ENDOCRINOLOGY, 2003, 179 (01) :15-23
[6]   Protein expression profiles in human breast ductal carcinoma and histologically normal tissue [J].
Bini, L ;
Magi, B ;
Marzocchi, B ;
Arcuri, F ;
Tripodi, S ;
Cintorino, M ;
Sanchez, JC ;
Frutiger, S ;
Hughes, G ;
Pallini, V ;
Hochstrasser, DF ;
Tosi, P .
ELECTROPHORESIS, 1997, 18 (15) :2832-2841
[7]   A NONLINEAR WIDE-RANGE IMMOBILIZED PH GRADIENT FOR 2-DIMENSIONAL ELECTROPHORESIS AND ITS DEFINITION IN A RELEVANT PH SCALE [J].
BJELLQVIST, B ;
PASQUALI, C ;
RAVIER, F ;
SANCHEZ, JC ;
HOCHSTRASSER, D .
ELECTROPHORESIS, 1993, 14 (12) :1357-1365
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71
[10]  
Costabel U, 2001, EUR RESPIR J, V18, p56S